Brain Cancer | Tumor

CURE’s brain cancer page features the latest cancer news and updates on brain cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in brain cancer.

Danyelza Added to NCCN Guidelines for High-Risk Neuroblastoma

May 8th 2025, 3:00pm

Article

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of brain cancer.

AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy

May 5th 2025, 4:00pm

Article

An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.

Larger Tumor Size Linked to Higher Mortality Risk in Brain Cancer

April 30th 2025, 3:18pm

Article

Investigators shared real-world data showing a clear and consistent association between increased tumor size and mortality for patients with brain cancer.

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

April 23rd 2025, 2:59pm

Article

The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.

Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025

April 22nd 2025, 5:40pm

Article

People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate.

TLX101 Demonstrated Efficacy in Recurrent High-Grade Glioma

April 16th 2025, 7:00pm

Article

TLX101 therapy was efficacious in recurrent high-grade glioma, a type of brain cancer, according to preliminary results from the phase 2 IPAX-Linz study.

Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas

April 15th 2025, 3:00pm

Article

A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September.

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

April 4th 2025, 3:12pm

Article

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma

April 2nd 2025, 9:00pm

Article

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.

A New Comprehensive Hereditary Cancer Solution Has Been Launched

April 2nd 2025, 3:00pm

Article

A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.